S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.37
+1.69
+10.13%
SKYE · Skye Bioscience, Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Skye Bioscience Inc (SKYE)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$1.65
+0.01
(+0.61%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$1.65
$1.65
$1.65
52-WEEK RANGE
$1.65
$1.50
$13.28
What's happening
- SKYE is up 0.61% today, trading at $1.65. — Live quote
- It's trading within 3% of its 52-week low ($1.50). (Finnhub fundamentals)
- Volume today (443) is well below its 3-month average of 68,730. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 18 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-1.68 actual vs. $-2.01 estimated (+16.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 5
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (10 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SKYE
-73.00%
vs S&P 500
-85.78%
1-YEAR RETURN
SKYE
-84.77%
vs S&P 500
-99.34%
6-MONTH RETURN
SKYE
-73.00%
3-MONTH RETURN
SKYE
-68.36%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.68
Est. $-2.01
BEAT +16.6%
2026-04-26 (Q1 2026)
$-2.56
Est. $-2.52
MISS -1.5%
2026-01-26 (Q4 2025)
$-2.88
Est. $-2.42
MISS -19.0%
2025-10-26 (Q3 2025)
$-2.56
Est. $-2.71
BEAT +5.6%
Valuation Measures & Ratios
Enterprise Value4-$1.2M
Forward P/E5—
PEG Ratio6-0.01
Price / Sales (TTM1)25.62
Price / Book72.28
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin-3.57%
Operating Margin-7.14%
Return on Equity (ROE8)-217.27%
Return on Assets (ROA9)-201.79%
Avg Volume (3M)68,730
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $214.5M | $188.0M | $1.25B | $1.33B | $504.4M |
| P/E | -4.00 | -3.48 | -27.47 | -32.89 | -18.06 |
| Price/Book | -431.23 | 20.86 | 37.97 | 30.52 | 8.51 |
| EV/EBITDA | -3.78 | -3.26 | -25.79 | — | — |
| ROE | 10793.23% | -599.13% | -138.20% | -92.79% | -47.13% |
| ROA | -486.46% | -278.07% | -109.82% | -77.70% | -43.10% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short147,954
Change from Prior Settlement+26.36%
% of Float—
Days to Cover (Short Ratio)1.74
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-09-24; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -3.6%. Finnhub fundamentals ↗
- Trailing 52-week price return is -84.8%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SKYE
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Operating income | -$11.1M | -$12.7M | -$13.3M | -$18.2M | -$11.8M | -$5.0M | -$8.4M | -$6.2M |
| Net income | -$10.8M | -$12.5M | -$12.8M | -$17.6M | -$11.1M | -$3.9M | -$7.9M | -$5.0M |
| EPS (diluted) | $-0.27 | $-0.32 | $-0.32 | $-0.44 | $-0.28 | $-0.10 | $-0.20 | $-0.18 |
| EPS (basic) | $-0.27 | $-0.32 | $-0.32 | $-0.44 | $-0.28 | $-0.10 | $-0.20 | $-0.18 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $11.0M | $19.4M | $28.3M | $41.3M | $52.2M | $64.8M | $72.8M | $81.5M |
| Total liabilities | $11.5M | $10.4M | $8.3M | $8.5M | $8.5M | $5.5M | $4.6M | $5.7M |
| Stockholders' equity | -$497.3K | $9.0M | $20.0M | $32.8M | $43.7M | $59.3M | $68.2M | $75.8M |
| Total current assets | $11.0M | $18.6M | $27.1M | $39.9M | $50.6M | $63.0M | $70.8M | $79.8M |
| Total current liabilities | $11.5M | $10.4M | $8.2M | $8.4M | $8.3M | $5.3M | $4.3M | $5.6M |
| Cash & equivalents | $8.1M | $8.1M | $5.9M | $18.4M | $23.8M | $46.4M | $68.4M | $67.4M |
| Marketable securities (current) | $2.0M | $9.0M | $19.9M | $16.9M | $24.7M | $12.8M | $0 | — |
| Accounts receivable | — | — | — | — | — | — | — | — |
| Other current assets | $479.6K | $234.8K | $852.0K | $900.2K | $733.4K | $3.2M | $2.2M | $2.7M |
| Property, plant & equipment | $32.9K | $756.1K | $898.9K | $1.0M | $1.2M | $1.3M | $1.4M | $1.5M |
| Other non-current assets | $8.3K | $35.9K | $53.9K | $53.9K | $53.9K | $53.9K | $53.9K | $26.3K |
| Accounts payable | $4.3M | $3.9M | $2.0M | $2.8M | $3.2M | $1.7M | $569.3K | $780.0K |
| Accrued liabilities | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Other current liabilities | $966.1K | $3.3M | $2.6M | $2.4M | $2.2M | $847.8K | $654.2K | $2.1M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Common stock & paid-in capital | $35.1K | $35.1K | $33.4K | $31.0K | $31.0K | $31.0K | $31.0K | $30.3K |
| Retained earnings | -$210.2M | -$199.4M | -$186.9M | -$172.4M | -$159.7M | -$142.1M | -$130.9M | -$121.2M |
| Accumulated other comprehensive income (loss) | — | — | — | — | — | — | — | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.1M | -$8.6M | -$9.8M | -$13.4M | -$10.7M | -$9.2M | -$8.2M | -$5.3M |
| Investing cash flow | $7.1M | $10.9M | -$2.8M | $8.0M | -$11.9M | -$12.8M | $90.4K | -$1.4M |
| Financing cash flow | -$101.0K | -$71.5K | $11.4K | $0 | $18.2K | $0 | $5.6K | $0 |
| Free cash flow | -$7.1M | -$8.6M | -$9.8M | -$13.4M | -$10.7M | -$9.2M | -$8.2M | -$6.8M |
| Capital expenditures | $0 | $0 | $0 | $0 | $0 | $6.3K | $50.0K | $1.5M |
| Depreciation & amortization | $157.6K | $172.9K | $180.0K | $178.9K | $187.1K | $177.4K | $175.3K | $66.0K |
| Share-based compensation | $1.3M | $1.5M | $1.6M | $1.9M | $2.0M | $2.2M | $2.1M | $1.9M |
| Change in accounts receivable | — | — | — | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — | — | — | — |
| Debt issued | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | — | — | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating income | -$58.2M | -$30.2M | -$34.7M | -$18.3M | -$7.8M |
| Net income | -$55.9M | -$26.6M | -$37.6M | -$19.5M | -$8.5M |
| EPS (diluted) | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 |
| EPS (basic) | $-1.41 | $-0.73 | $-5.37 | $-8.77 | $-0.02 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $28.3M | $72.8M | $11.9M | $9.1M | $9.9M |
| Total liabilities | $8.3M | $4.6M | $14.1M | $12.1M | $4.0M |
| Stockholders' equity | $20.0M | $68.2M | -$2.1M | -$3.0M | $5.9M |
| Total current assets | $27.1M | $70.8M | $11.7M | $8.9M | $9.6M |
| Total current liabilities | $8.2M | $4.3M | $13.9M | $12.1M | $3.9M |
| Cash & equivalents | $5.9M | $68.4M | $1.3M | — | — |
| Marketable securities (current) | $19.9M | $0 | — | — | — |
| Accounts receivable | — | — | — | — | — |
| Other current assets | $852.0K | $2.2M | $1.1M | $481.6K | $56.9K |
| Property, plant & equipment | $898.9K | $1.4M | $43.3K | $87.9K | $87.7K |
| Other non-current assets | $53.9K | $53.9K | $8.3K | $8.3K | $8.3K |
| Accounts payable | $2.0M | $569.3K | — | $1.7M | $897.9K |
| Accrued liabilities | — | — | — | — | — |
| Other current liabilities | $2.6M | $654.2K | — | $1.4M | $375.8K |
| Common stock & paid-in capital | $33.4K | $31.0K | $12.3K | $3.7K | $476.1K |
| Retained earnings | -$186.9M | -$130.9M | -$104.4M | -$66.7M | -$47.3M |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$43.1M | -$25.2M | -$14.0M | -$12.7M | -$6.5M |
| Investing cash flow | -$19.5M | -$245.6K | $6.6M | $5.2M | -$90.9K |
| Financing cash flow | $29.6K | $83.6M | $16.4M | -$208.8K | $13.1M |
| Free cash flow | -$43.1M | -$26.8M | -$14.0M | -$12.8M | -$6.6M |
| Capital expenditures | $6.3K | $1.6M | $12.6K | $28.1K | $90.9K |
| Depreciation & amortization | $723.4K | $298.6K | $124.3K | — | — |
| Share-based compensation | $7.8M | $8.3M | $987.5K | $629.0K | $869.2K |
| Change in accounts receivable | — | — | — | — | — |
| Change in accounts payable | — | — | — | — | — |
| Debt issued | — | — | — | — | — |
| Debt repaid | — | — | — | — | — |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SKYE as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-08-07 to 2026-09-23
Recent transactions
- Insiders have net sold 1,115,622 shares over the last 182 days, across 0 purchases and 30 sales.
- Most recent: Schwab Andrew J. (Reporting person) — Open market sale of 114,851 shares on 2026-09-23.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)1,115,622 sh(30 txns)
Net Shares-1,115,622
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Schwab Andrew J. | Reporting person | Open market sale | 2026-09-23 | 114,851 |
| 5AM Partners VII, LLC | Reporting person | Open market sale | 2026-09-23 | 114,851 |
| DHILLON PUNIT | Chief Executive Officer | Grant / award | 2026-08-07 | 1,090,000 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-23 | Schwab Andrew J. | Reporting person | Open market sale | 114,851 | $1.61 |
| 2026-09-23 | Schwab Andrew J. | Reporting person | Open market sale | 4,528 | $1.61 |
| 2026-09-23 | 5AM Partners VII, LLC | Reporting person | Open market sale | 114,851 | $1.61 |
| 2026-09-23 | 5AM Partners VII, LLC | Reporting person | Open market sale | 4,528 | $1.61 |
| 2026-09-22 | Schwab Andrew J. | Reporting person | Open market sale | 27,612 | $1.65 |
| 2026-09-22 | Schwab Andrew J. | Reporting person | Open market sale | 1,088 | $1.65 |
| 2026-09-22 | 5AM Partners VII, LLC | Reporting person | Open market sale | 27,612 | $1.65 |
| 2026-09-22 | 5AM Partners VII, LLC | Reporting person | Open market sale | 1,088 | $1.65 |
| 2026-09-16 | Schwab Andrew J. | Reporting person | Open market sale | 32,607 | $1.91 |
| 2026-09-16 | Schwab Andrew J. | Reporting person | Open market sale | 1,285 | $1.91 |
| 2026-09-16 | 5AM Partners VII, LLC | Reporting person | Open market sale | 32,607 | $1.91 |
| 2026-09-16 | 5AM Partners VII, LLC | Reporting person | Open market sale | 1,285 | $1.91 |
| 2026-08-20 | Schwab Andrew J. | Reporting person | Open market sale | 1,159 | $0.32 |
| 2026-08-20 | Schwab Andrew J. | Reporting person | Open market sale | 46 | $0.32 |
| 2026-08-20 | Schwab Andrew J. | Reporting person | Open market sale | 6,495 | $0.32 |
| 2026-08-20 | 5AM Partners VII, LLC | Reporting person | Open market sale | 1,159 | $0.32 |
| 2026-08-20 | 5AM Partners VII, LLC | Reporting person | Open market sale | 46 | $0.32 |
| 2026-08-20 | 5AM Partners VII, LLC | Reporting person | Open market sale | 6,495 | $0.32 |
| 2026-08-19 | Schwab Andrew J. | Reporting person | Open market sale | 10,255 | $0.35 |
| 2026-08-19 | Schwab Andrew J. | Reporting person | Open market sale | 409 | $0.35 |
| 2026-08-19 | Schwab Andrew J. | Reporting person | Open market sale | 57,476 | $0.35 |
| 2026-08-19 | 5AM Partners VII, LLC | Reporting person | Open market sale | 10,255 | $0.35 |
| 2026-08-19 | 5AM Partners VII, LLC | Reporting person | Open market sale | 409 | $0.35 |
| 2026-08-19 | 5AM Partners VII, LLC | Reporting person | Open market sale | 57,476 | $0.35 |
| 2026-08-18 | Schwab Andrew J. | Reporting person | Open market sale | 45,090 | $0.38 |
| 2026-08-18 | Schwab Andrew J. | Reporting person | Open market sale | 1,830 | $0.38 |
| 2026-08-18 | Schwab Andrew J. | Reporting person | Open market sale | 253,080 | $0.38 |
| 2026-08-18 | 5AM Partners VII, LLC | Reporting person | Open market sale | 45,090 | $0.38 |
| 2026-08-18 | 5AM Partners VII, LLC | Reporting person | Open market sale | 1,830 | $0.38 |
| 2026-08-18 | 5AM Partners VII, LLC | Reporting person | Open market sale | 253,080 | $0.38 |
| 2026-08-07 | DHILLON PUNIT | Chief Executive Officer | Grant / award | 1,090,000 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 08:06 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-24 | 4 | 2026-09-22 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-11 | 8-K | 2026-09-08 | View on SEC.gov → |
| 2026-08-24 | 8-K | 2026-08-21 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-20 | 4 | 2026-08-18 | View on SEC.gov → |
| 2026-08-19 | 8-K | 2026-08-18 | View on SEC.gov → |
| 2026-08-14 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-14 | 8-K | 2026-08-12 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-07 | View on SEC.gov → |
Recent news
Headlines about SKYE (Skye Bioscience, Inc.). Links open the publisher — we don’t host full articles.
-
Tesco planns new forecourt for Isle of Skye
Forecourt Trader · 2026-10-22 -
Skye’s only Michelin-starred restaurant to close at end of month after 10 years
ScottishNews.com · 2026-10-19 -
Justine Skye - Say Who - le média des communautés influentes de notre époque
saywhomedia.com · 2026-10-17 -
TANG CAPITAL MANAGEMENT LLC Acquires 263,560 Shares of Skye Bios
GuruFocus · 2026-10-15 -
Skye Bioscience Inc (SKYE) (Q2 2026) Earnings Call Highlights: Strategic Pivot to Fibrex ...
Yahoo Finance · 2026-08-17 -
Skye Bioscience, Inc. (SKYE) Skye Bioscience, Inc. - M&A Call - Slideshow
Seeking Alpha · 2026-08-16 -
Skye Bioscience, Inc. (SKYE) M&A Call Prepared Remarks Transcript
Seeking Alpha · 2026-08-14 -
Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings
Yahoo Finance · 2026-08-14
No headlines in this category right now — try “All”.